BALAXI
BALAXI PHARMACEUTICALS LIMITED (BALAXI) Stock Analysis
BALAXI PHARMACEUTICALS LIMITED is an Indian pharmaceutical company manufacturing formulations and healthcare products. It markets medicines in domestic and international generic markets. The company operates manufacturing facilities in India. It is a listed small-cap pharma stock.
Healthcare › Drug Manufacturers - Specialty & Generic
₹22.30
-0.04% 1W | -48.50% 52W
Market Cap
123 CR
P/E Ratio
49.6
52W High
₹44.4
52W Low
₹15.2
Div. Yield
0%
Beta
0.7
50 DMA
₹23.5
200 DMA
₹23.6
Profit Margin
0.5%
Inst. Own.
0%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65.96 | 54.72 | 60.79 | 59.83 | 65.62 | 77.38 | 73.29 | 76.27 | 70.74 | 56.18 | 72.54 | 70.71 | 80.68 |
| Expenses | 57.12 | 43.96 | 47.14 | 46.36 | 55.53 | 66.79 | 69.30 | 63.72 | 66.58 | 55.02 | 69.45 | 70.59 | 76.02 |
| Operating Profit | 8.84 | 10.76 | 13.65 | 13.47 | 10.09 | 10.59 | 3.99 | 12.55 | 4.16 | 1.16 | 3.09 | 0.12 | 4.66 |
| OPM % | 13.40% | 19.66% | 22.45% | 22.51% | 15.38% | 13.69% | 5.44% | 16.45% | 5.88% | 2.06% | 4.26% | 0.17% | 5.78% |
| Other Income | -47.68 | 5.93 | 1.51 | -0.70 | -1.85 | -4.11 | 3.94 | -1.69 | -1.78 | 1.59 | 0.10 | 2.92 | -0.99 |
| Interest | 0.29 | 0.37 | 0.41 | 0.61 | 0.37 | 0.45 | 1.38 | 0.74 | 1.01 | 0.89 | 1.02 | 0.99 | 0.73 |
| Depreciation | 0.29 | 0.66 | 0.48 | 0.67 | 0.49 | 0.46 | 0.48 | 0.46 | 0.46 | 0.48 | 0.56 | 0.65 | 0.85 |
| Profit before tax | -39.42 | 15.66 | 14.27 | 11.49 | 7.38 | 5.57 | 6.07 | 9.66 | 0.91 | 1.38 | 1.61 | 1.40 | 2.09 |
| Tax % | 4.90% | 7.92% | 4.77% | 4.87% | 12.06% | 17.41% | 11.70% | 10.56% | 67.03% | 84.06% | 80.75% | 56.43% | 38.28% |
| Net Profit | -41.34 | 14.43 | 13.59 | 10.93 | 6.48 | 4.59 | 5.36 | 8.64 | 0.29 | 0.21 | 0.31 | 0.61 | 1.30 |
| EPS in Rs | -8.07 | 2.82 | 2.65 | 2.01 | 1.17 | 0.83 | 0.97 | 1.57 | 0.05 | 0.04 | 0.06 | 0.11 | 0.24 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 14 | 46 | 231 | 279 | 336 | 241 | 293 | 270 | 280 |
| Expenses | 12 | 37 | 189 | 229 | 279 | 197 | 254 | 261 | 271 |
| Operating Profit | 2 | 8 | 43 | 51 | 57 | 45 | 38 | 10 | 9 |
| OPM % | 11% | 18% | 18% | 18% | 17% | 18% | 13% | 3.5% | 3.2% |
| Other Income | 1 | 1 | 2 | 5 | 3 | -38 | -4 | 3 | 4 |
| Interest | -0 | 0 | 0 | 1 | 1 | 3 | 4 | 5 | 4 |
| Depreciation | -0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 2 | 9 | 44 | 55 | 57 | 2 | 29 | 5 | 6 |
| Tax % | 19% | 31% | 14% | 13% | 19% | 219% | 13% | 73% | |
| Net Profit | 2 | 6 | 38 | 48 | 46 | -2 | 25 | 1 | 2 |
| EPS in Rs | 1.30 | 1.22 | 7.63 | 9.53 | 9.03 | -0.44 | 4.54 | 0.26 | 0.45 |
| Dividend Payout % | -0% | -0% | -0% | 1% | -0% | -0% | -0% | -0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -7.0% | 3.0% | – |
| Profit CAGR | -69.0% | -48.0% | – |
Shareholding Pattern
Promoters65.99%
FIIs8.87%
DIIs0.02%
Public25.12%
Promoters65.99%
FIIs3.50%
DIIs0.02%
Public30.49%
Promoters65.99%
FIIs1.74%
DIIs0.02%
Public32.24%
Promoters65.99%
DIIs2.56%
Public31.45%
Promoters65.99%
DIIs2.56%
Public31.45%
Promoters71.57%
FIIs18.66%
DIIs0.03%
Public9.75%
Promoters66.86%
FIIs17.21%
DIIs0.02%
Public15.91%
Promoters65.99%
FIIs16.02%
DIIs0.02%
Public17.96%
Promoters65.99%
DIIs2.56%
Public31.45%
Promoters65.99%
DIIs2.56%
Public31.45%
BALAXI
Holdings Analysis
Key strengths & risk signals
51
Overall
46
Fundamental
56
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 48.5% in the last year.
WEAK POSITION! Current price (22.3) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.0% (1 week), 5.7% (1 month), 7.6% (3 months).
Strengths (4)
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 61,460 vs down days: 35,070. Ratio: 1.75x
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
NEUTRAL! RSI at 42.7 - balanced momentum.
Fundamental & Technical Analysis
51Overall
46Fundamental
56Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -7.1% (DECLINING, 2/15). Profit CAGR: -68.6% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 0.5% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 10.18% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (23.5) is below 200-day average (23.6) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (22.3) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 48.5% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 61,460 vs down days: 35,070. Ratio: 1.75x
RSI
3/5
NEUTRAL! RSI at 42.7 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 24.3% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.0% (1 week), 5.7% (1 month), 7.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BALAXI | ₹22.30 | 49.6 | 0.5% | -7.1% | -68.6% | -48.5% | 51 | APPROACHING SUPPORT | +333.3% | +116.7% | +14.1% | +14.1% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -16.8% | 47 | BREAKDOWN | -52.8% | +8.7% | +27.3% | +2.9% |
| ALPA | ₹57.00 | 33.9 | 3.8% | 4.3% | 6.1% | -35.3% | 47 | APPROACHING SUPPORT | -91.5% | -28.6% | +25.1% | -23.9% |
| VAISHALI | ₹7.90 | – | 4.1% | 18.0% | -15.2% | -26.8% | 52 | BREAKDOWN | – | +278.0% | – | -15.0% |
| PAR | ₹117.10 | 11 | 13.3% | 11.0% | 1.0% | +21.6% | 66 | BREAKDOWN | +42.7% | +423.3% | +20.3% | +59.6% |
| BALPHARMA | ₹93.10 | 20.5 | 2.2% | 0.1% | 34.7% | +18.7% | 66 | CONSOLIDATING UP | +450.0% | -69.4% | +34.4% | +5.4% |
| NATCAPSUQ | ₹160.00 | – | -8.1% | 3.6% | – | -32.4% | 46 | BREAKDOWN | +1.8% | +14.0% | +7.7% | -16.8% |
| VIVIMEDLAB | ₹7.20 | – | -231.3% | -27.9% | – | +33.1% | 50 | CONSOLIDATION | +2,526.8% | +786.1% | -53.1% | -25.0% |
Data from TradeAlone · Updated daily
No news tagged for BALAXI yet.
